Europe's Innovation Surge: New Funds Drive FoodTech, Deep Tech, and HealthTech Growth
December 17, 2025, 9:31 pm
European venture capital surges. FoodLabs secured over €105M for its third fund, targeting food system innovation, from farm to health. University2Ventures launched a €60M fund, focusing on deep tech spin-offs in AI, clean tech, and industrial solutions. Catalpa Ventures debuted with a €30M fund, backing early-stage European HealthTech. FinTech giant Raisin reported €247M revenue, maintaining unicorn status, and plans an IPO. However, the startup ecosystem shows challenges, with Hemptastic dissolving. Mirantus Health secured €5.5M for its research-driven health solutions. This landscape reflects robust investment, strategic sector focus, and ongoing market evolution.
Venture capital flows vigorously across Europe. Significant funds close. New investors emerge. Startups demonstrate growth or face challenges. The continent's innovation ecosystem evolves rapidly. Investment targets critical sectors. Food, health, and deep technology lead the charge. This dynamic environment shapes future markets.
Berlin-based FoodLabs completed its third fund. It raised over €105 million. This capital targets food system challenges. The firm focuses on agriculture, food security, and health. FoodLabs plans initial checks from $100,000 to $2 million. This supports 25 to 30 early-stage startups. The fund emphasizes "lab-to-shelf" innovation. It combines venture building with capital and industrial access. This accelerates commercial product development. Strategic investors include REWE Group, Henkel, and Bitburger Holding.
FoodLabs backs pioneering companies. Voltrac develops electric autonomous vehicles. Aardaia works on climate-resilient heritage crops. BYVIDA offers nutritional supplements. Founder Christophe F. Maire champions a product-builder mindset. He previously co-founded Gate5 and Plazes. FoodLabs' approach centers on operational support. It tackles structural food system problems. This robust fund closing signals strong investor confidence. It highlights the urgent need for food innovation. Europe's FoodTech sector gains momentum.
The investment landscape expands with new specialized funds. University2Ventures (U2V) launched. It succeeds Earlybird-X. The new early-stage investor focuses on university and research spin-offs. U2V's first fund aims for €60 million. Investment targets include Artificial Intelligence, Novel Computing, Industrial Tech, and Clean Tech. This includes dual-use technologies. The U2V team brings extensive venture experience. They plan up to 25 pre-seed and seed investments. U2V connects research founders with industry partners. This accelerates product development and market entry. Earlybird restructured in mid-2024. U2V marks a strategic pivot for deep tech investment. European deep tech ventures find new support.
Catalpa Ventures also debuts. This new HealthTech investor targets €30 million for its first fund. Catalpa focuses on early-stage European HealthTech companies. Pre-seed and seed rounds are priorities. The Luxembourg-based firm aims for a Q1 2027 final closing. It plans 15 to 20 investments over four years. Initial investments range from €300,000 to €1.5 million. Noah Labs is its first investment. This Berlin startup monitors cardiovascular diseases from home. Catalpa Ventures addresses a critical need. It supports innovation in healthcare technology. HealthTech investment remains robust.
Berlin FinTech unicorn Raisin demonstrates robust financial performance. The company generated €247 million in revenue in 2024. This marks a significant increase from €173 million the previous year. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) reached €34.38 million. This represents solid operational profitability. However, high marketing costs of €77 million impacted net profitability. A substantial €20 million one-time write-off also affected the EBIT.
Raisin holds a €2.3 billion valuation. The company employed an average of 710 staff in 2024. Management projects continued strong revenue growth for 2025. This performance fuels speculation about a long-planned Initial Public Offering (IPO). The FinTech sector remains a key driver of European innovation. Raisin exemplifies successful scaling in this competitive space. Its strong revenue figures underscore market demand for its services. European FinTech continues its rapid expansion.
The startup world features both triumphs and closures. Hemptastic, a hemp bar company, ceased operations. Katjes Greenfood, its parent company, dissolved Hemptastic Food & Beverage GmbH. Hemptastic initially focused on hemp soda. It faced insolvency in 2018. Katjesgreenfood acquired and relaunched it with hemp bars. The ultimate closure highlights market volatility. Not all ventures succeed despite new ownership. Startup failure is part of the ecosystem.
Meanwhile, other startups secure crucial funding. Mirantus Health, a Berlin-based firm, raised €5.5 million. The company originated from a research project. Its solutions address health challenges. Founder Dominik Pederzani noted the solution's effectiveness. This funding round supports its expansion. Such investments drive progress in specialized health solutions. The broader health tech sector shows continued investor interest. New health startups attract capital.
The European innovation ecosystem demonstrates resilience. It shows strategic focus. Investors direct capital into vital areas. Food security, healthcare, and advanced technologies receive significant attention. New funds like FoodLabs, U2V, and Catalpa Ventures solidify this trend. They provide essential early-stage capital. Unicorns like Raisin show scalability. They inspire future founders. Challenges remain, as seen with Hemptastic. However, the overall outlook is positive. Europe continues to foster groundbreaking companies. These ventures address global needs. They contribute to economic growth. The flow of venture capital remains critical. It underpins the continent's competitive edge. The future promises further innovation and growth. European startup investment fuels progress.
Venture capital flows vigorously across Europe. Significant funds close. New investors emerge. Startups demonstrate growth or face challenges. The continent's innovation ecosystem evolves rapidly. Investment targets critical sectors. Food, health, and deep technology lead the charge. This dynamic environment shapes future markets.
FoodLabs Fuels Food System Revolution
Berlin-based FoodLabs completed its third fund. It raised over €105 million. This capital targets food system challenges. The firm focuses on agriculture, food security, and health. FoodLabs plans initial checks from $100,000 to $2 million. This supports 25 to 30 early-stage startups. The fund emphasizes "lab-to-shelf" innovation. It combines venture building with capital and industrial access. This accelerates commercial product development. Strategic investors include REWE Group, Henkel, and Bitburger Holding.
FoodLabs backs pioneering companies. Voltrac develops electric autonomous vehicles. Aardaia works on climate-resilient heritage crops. BYVIDA offers nutritional supplements. Founder Christophe F. Maire champions a product-builder mindset. He previously co-founded Gate5 and Plazes. FoodLabs' approach centers on operational support. It tackles structural food system problems. This robust fund closing signals strong investor confidence. It highlights the urgent need for food innovation. Europe's FoodTech sector gains momentum.
New Deep Tech and HealthTech Funds Emerge
The investment landscape expands with new specialized funds. University2Ventures (U2V) launched. It succeeds Earlybird-X. The new early-stage investor focuses on university and research spin-offs. U2V's first fund aims for €60 million. Investment targets include Artificial Intelligence, Novel Computing, Industrial Tech, and Clean Tech. This includes dual-use technologies. The U2V team brings extensive venture experience. They plan up to 25 pre-seed and seed investments. U2V connects research founders with industry partners. This accelerates product development and market entry. Earlybird restructured in mid-2024. U2V marks a strategic pivot for deep tech investment. European deep tech ventures find new support.
Catalpa Ventures also debuts. This new HealthTech investor targets €30 million for its first fund. Catalpa focuses on early-stage European HealthTech companies. Pre-seed and seed rounds are priorities. The Luxembourg-based firm aims for a Q1 2027 final closing. It plans 15 to 20 investments over four years. Initial investments range from €300,000 to €1.5 million. Noah Labs is its first investment. This Berlin startup monitors cardiovascular diseases from home. Catalpa Ventures addresses a critical need. It supports innovation in healthcare technology. HealthTech investment remains robust.
FinTech Unicorn Raisin Posts Strong Growth
Berlin FinTech unicorn Raisin demonstrates robust financial performance. The company generated €247 million in revenue in 2024. This marks a significant increase from €173 million the previous year. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) reached €34.38 million. This represents solid operational profitability. However, high marketing costs of €77 million impacted net profitability. A substantial €20 million one-time write-off also affected the EBIT.
Raisin holds a €2.3 billion valuation. The company employed an average of 710 staff in 2024. Management projects continued strong revenue growth for 2025. This performance fuels speculation about a long-planned Initial Public Offering (IPO). The FinTech sector remains a key driver of European innovation. Raisin exemplifies successful scaling in this competitive space. Its strong revenue figures underscore market demand for its services. European FinTech continues its rapid expansion.
Startup Challenges and New Funding Rounds
The startup world features both triumphs and closures. Hemptastic, a hemp bar company, ceased operations. Katjes Greenfood, its parent company, dissolved Hemptastic Food & Beverage GmbH. Hemptastic initially focused on hemp soda. It faced insolvency in 2018. Katjesgreenfood acquired and relaunched it with hemp bars. The ultimate closure highlights market volatility. Not all ventures succeed despite new ownership. Startup failure is part of the ecosystem.
Meanwhile, other startups secure crucial funding. Mirantus Health, a Berlin-based firm, raised €5.5 million. The company originated from a research project. Its solutions address health challenges. Founder Dominik Pederzani noted the solution's effectiveness. This funding round supports its expansion. Such investments drive progress in specialized health solutions. The broader health tech sector shows continued investor interest. New health startups attract capital.
Europe's Dynamic Innovation Landscape
The European innovation ecosystem demonstrates resilience. It shows strategic focus. Investors direct capital into vital areas. Food security, healthcare, and advanced technologies receive significant attention. New funds like FoodLabs, U2V, and Catalpa Ventures solidify this trend. They provide essential early-stage capital. Unicorns like Raisin show scalability. They inspire future founders. Challenges remain, as seen with Hemptastic. However, the overall outlook is positive. Europe continues to foster groundbreaking companies. These ventures address global needs. They contribute to economic growth. The flow of venture capital remains critical. It underpins the continent's competitive edge. The future promises further innovation and growth. European startup investment fuels progress.